Treatment With Tiotropium Plus Olodaterol Respimat Improves Physical Functioning Of COPD Patients In A Real Life Setting

被引:0
|
作者
Haensel, M. [1 ]
Glaab, T. [1 ]
Sauer, R. [2 ]
Rubin, R.
Buhl, R. [3 ]
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[2] Lung Ctr Ulm, Ulm, Germany
[3] Mainz Univ Hosp, Mainz, Germany
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6810
引用
收藏
页数:1
相关论文
共 50 条
  • [31] ANALYSIS OF THE EFFICACY AND SAFETY OF THE COMBINATION OF TIOTROPIUM plus OLODATEROL IN PATIENTS WITH COPD BY PREVIOUS USAGE OF INHALED CORTICOSTEROIDS
    Korn, S.
    Buhl, R.
    Groenke, L.
    Korducki, L.
    Amato, V. C.
    Ferguson, G. T.
    Abrahams, R.
    THORAX, 2015, 70 : A37 - A37
  • [32] Lung Function Response With Tiotropium plus Olodaterol Maintenance Treatment in Patients With COPD in the TONADO and OTEMTO Studies: A Subgroup Analysis by Age
    Ferguson, Gary
    Clerisme-Beaty, Emmanuelle
    Groenke, Lars
    Voss, Florian
    Karpel, Jill
    CHEST, 2015, 148 (04)
  • [33] THE FIXED-DOSE COMBINATION OF TIOTROPIUM plus OLODATEROL HAS A RAPID ONSET OF ACTION IN PATIENTS WITH COPD
    Veale, A.
    Ferguson, G.
    Pizzichini, E.
    Flezar, M.
    Groenke, L.
    Korducki, L.
    RESPIROLOGY, 2016, 21 : 129 - 129
  • [34] Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies
    LaForce, Craig
    Derom, Eric
    Bothner, Ulrich
    Kloer, Isabel M.
    Trampisch, Matthias
    Buhl, Roland
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1819 - 1831
  • [35] ANALYSIS OF THE EFFICACY AND SAFETY OF TIOTROPIUM AND OLODATEROL FIXED-DOSE COMBINATION VIA THE RESPIMAT® IN PATIENTS WITH COPD BY DISEASE SEVERITY: TONADO TRIALS
    Ichinose, Masakazu
    Takizawa, Ayako
    Groenke, Lars
    Voss, Florian
    Fukuchi, Yoshinosuke
    RESPIROLOGY, 2015, 20 : 66 - 66
  • [36] LUNG FUNCTION WITH TIOTROPIUM PLUS OLODATEROL IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Bai, Chunxue
    Buhl, Roland
    Lee, Sang Haak
    Lee, Kwan Ho
    Joens, Olaf
    Zhao, Yihua
    Ichinose, Masakazu
    RESPIROLOGY, 2015, 20 : 53 - 53
  • [37] The fixed-dose combination of tiotropium plus olodaterol has a rapid onset of action in patients with COPD
    Ferguson, Gary T.
    Pizzichini, Emilio
    Flezar, Matjaz
    Groenke, Lars
    Korducki, Lawrence
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [38] Benefits Of Tiotropium plus Olodaterol On Symptoms And Health-Related Quality Of Life In Patients With Moderate To Severe COPD With Chronic Bronchitis And/or Emphysema
    Ferguson, G. T.
    Abrahams, R.
    Bjermer, L.
    Gronke, L.
    Vob, F.
    Singh, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [39] First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naive Chronic Obstructive Pulmonary Disease
    Takahashi, Koichiro
    Uchida, Masaru
    Kato, Go
    Takamori, Ayako
    Kinoshita, Takashi
    Yoshida, Makoto
    Tajiri, Ryo
    Kojima, Keisuke
    Inoue, Hiroshi
    Kobayashi, Hiromi
    Sadamatsu, Hironori
    Tashiro, Hiroki
    Tanaka, Masahide
    Hayashi, Shinichiro
    Kawaguchi, Atsushi
    Kimura, Shinya
    Sueoka-Aragane, Naoko
    Kawayama, Tomotaka
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2115 - 2126
  • [40] The efficacy and safety of combined tiotropium and olodaterol via the Respimat® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies
    Ichinose, Masakazu
    Taniguchi, Hiroyuki
    Takizawa, Ayako
    Gronke, Lars
    Loaiza, Lazaro
    Voss, Florian
    Zhao, Yihua
    Fukuchi, Yoshinosuke
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2017 - 2027